Biotech Sector Faces Headwinds While Select BlueChip Stocks Stand Out ORLA Q1 2026 Earnings Slight EPS Miss Overshadowed by Strong Operational Performance and Stock Rally Novartis Raises FullYear Sales and Profit Guidance Signaling Strong Operational Momentum